Impact of human immunodeficiency virus infection in pregnant women on variant-specific immunity to malaria.

Edson G Dembo, Victor Mwapasa, Jacqui Montgomery, Alister G Craig, Kimberly A Porter, Steven R Meshnick, Malcolm E Molyneux, Stephen J Rogerson
Author Information
  1. Edson G Dembo: Malawi-Liverpool-Wellcome Trust Clinical Research Programme, College of Medicine, University of Malawi, Blantyre, Malawi.

Abstract

Human immunodeficiency virus (HIV) increases susceptibility to Plasmodium falciparum infection, and this has most clearly been demonstrated in pregnant women. Variant surface antigens on the surfaces of erythrocytes infected with P. falciparum are major targets of protective immunity. We studied the impact of HIV infection on pregnant women's humoral immunity to variant surface antigens expressed by placental and pediatric isolates of P. falciparum. By flow cytometry, sera from HIV-infected women more frequently lacked antibodies to these antigens than sera from HIV-uninfected women. This difference was similar in magnitude for pediatric isolates (unadjusted odds ratio [OR] = 6.36; 95% confidence interval [CI] = 1.14, 35.32; P < 0.05) and placental isolates (unadjusted OR = 6.47; 95% CI = 0.75, 55.64; P < 0.10). We divided women into high and low responders on the basis of their antibody levels. After adjustment for CD4 count, maternal age, and gravidity, we found that HIV-infected women more frequently had low responses to both pediatric isolates (OR = 5.34; 95% CI = 1.23, 23.16; P = 0.025) and placental isolates (OR = 4.14; 95% CI = 1.71, 10.02; P = 0.002). The relative quantity of antibodies to both pediatric isolates (P = 0.035) and placental isolates (P = 0.005) was lower in HIV-infected women than in HIV-uninfected women. HIV infection has a broad impact on variant-specific immunity, which may explain the susceptibility of infected individuals to clinical malaria episodes.

References

  1. J Infect Dis. 2006 Jan 1;193(1):9-15 [PMID: 16323126]
  2. J Infect Dis. 2005 Sep 15;192(6):984-91 [PMID: 16107950]
  3. Lancet. 2000 Sep 23;356(9235):1051-6 [PMID: 11009139]
  4. J Infect. 2003 Apr;46(3):164-72 [PMID: 12643865]
  5. Infect Immun. 2003 Nov;71(11):6620-3 [PMID: 14573685]
  6. Lancet. 2004 Jan 24;363(9405):283-9 [PMID: 14751701]
  7. AIDS. 2004 Apr 30;18(7):1051-9 [PMID: 15096809]
  8. Lancet. 2004 Jun 5;363(9424):1860-7 [PMID: 15183624]
  9. Am J Trop Med Hyg. 2004 Aug;71(2 Suppl):41-54 [PMID: 15331818]
  10. Bull World Health Organ. 1983;61(6):1005-16 [PMID: 6370484]
  11. Am J Trop Med Hyg. 1989 Nov;41(5):504-11 [PMID: 2683820]
  12. Ann Intern Med. 1993 Mar 1;118(5):390-2 [PMID: 8094281]
  13. Science. 1996 Jun 7;272(5267):1502-4 [PMID: 8633247]
  14. Nat Med. 1998 Mar;4(3):358-60 [PMID: 9500614]
  15. J Infect Dis. 1999 Aug;180(2):464-72 [PMID: 10395863]
  16. Lancet. 2005 Jan 15-21;365(9455):233-40 [PMID: 15652606]
  17. J Infect Dis. 2000 Jul;182(1):252-9 [PMID: 10882604]

Grants

  1. AI 49084/NIAID NIH HHS
  2. 074124/Wellcome Trust
  3. 063215/Wellcome Trust
  4. 071376/Wellcome Trust
  5. R01 AI049084/NIAID NIH HHS

MeSH Term

Animals
Antibodies
Antigenic Variation
Antigens, Surface
Child
Erythrocytes
Female
Flow Cytometry
HIV
HIV Infections
Humans
Malaria, Falciparum
Placenta
Plasmodium falciparum
Pregnancy
Pregnancy Complications, Infectious

Chemicals

Antibodies
Antigens, Surface